Literature DB >> 4291418

Specific antagonism to the direct and indirect action of angiotensin on isolated guinea-pig ileum.

T Godfraind, A Kaba, P Polster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4291418      PMCID: PMC1510842          DOI: 10.1111/j.1476-5381.1966.tb01877.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  8 in total

1.  STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE.

Authors:  H P RANG
Journal:  Br J Pharmacol Chemother       Date:  1964-04

2.  A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN.

Authors:  D REGOLI; J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

3.  CONTRACTILE RESPONSE TO HISTAMINE AND ACETYLCHOLINE OF MAMMALIAN SMOOTH MUSCLE IN A K-FREE MEDIUM.

Authors:  T GODFRAIND; A GODFRAIND-DEBECKER; P SPRUMONT
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-02

4.  THE CHANGES IN RESPONSE AND IN IONIC CONTENT OF SMOOTH MUSCLE PRODUCED BY ACETYLCHOLINE ACTON AND BY CALCIUM DEFICIENCY.

Authors:  W D PATON; A M ROTHSCHILD
Journal:  Br J Pharmacol Chemother       Date:  1965-04

5.  Stimulation of intestinal nervous elements by angiotensin.

Authors:  P A ROBERTSON; D RUBIN
Journal:  Br J Pharmacol Chemother       Date:  1962-08

6.  Stimulation of the coronary collateral circulation by lidoflazine (R 7904).

Authors:  W K Schaper; R Xhonneux; A H Jageneau
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-11-04

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  CINNARIZINE (R 516), A SPECIFIC ANGIOTENSINE-BLOCKING CORONARY VASODILATOR.

Authors:  W K SCHAPER; A H JAGENEAU; R XHONNEUX; J VANNUETEN; P A JANSSEN
Journal:  Life Sci (1962)       Date:  1963-12
  8 in total
  14 in total

1.  A further investigation into the energy dependence of angiotensin II-induced contractions of isolated smooth muscle preparations.

Authors:  A D Crocker; K A Wilson
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

Review 2.  Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Authors:  Théophile Godfraind
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  The action of angiotensin II on guinea-pig ileum and its modification by changes in sodium concentration.

Authors:  J R Blair-West; R Harding; J S McKenzie
Journal:  Br J Pharmacol Chemother       Date:  1967-10

Review 4.  [Relationship between the renin-angiotensin system and the autonomic nervous system].

Authors:  K Starke
Journal:  Klin Wochenschr       Date:  1972-12-01

5.  The action of angiotensin on the human colon in vitro.

Authors:  D J Fishlock; A Gunn
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

6.  Inhibition by lidoflazine of the contractile response of the rat isolated colon to angiotensin.

Authors:  D E Ellis; E Reit
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

7.  Effect of lidoflazine on norepinephrine, angiotensin and serotonin responses in isolated smooth muscle preparations.

Authors:  R K Türker; S O Kayaalp
Journal:  Experientia       Date:  1967-08-15

8.  Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris.

Authors:  B Brantmark; N Egelius; E Fabricius; M Jemt; G Palmborg; J Philipson; N Rönnegård
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

9.  Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine.

Authors:  A B Hawcock; J C Barnes
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

10.  Evidence against cholinergic mediation of the effect of angiotensin II on the guinea pig ileum.

Authors:  T B Paiva; G B Mendes; J Aboulafia; A C Paiva
Journal:  Pflugers Arch       Date:  1976-09-30       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.